Komori
Earnings Presentation9221FULUHASHI EPO CORPORATIONInformation and Communications, Services and Others

Supplementary Financial Results Presentation for the Second Quarter of the Fiscal Year Ending March 2027

For the second quarter of the fiscal year ending March 2027, revenue reached a record high, driven by the quantitative expansion of the biomaterials business and other factors, while operating profit and interim net income fell below the same period of the previous year due to increased personnel investment and depreciation expenses. The full-year forecast remains unchanged, with plans for higher revenue and operating profit, among other items, and an annual dividend forecast of ¥32.

Worth reading
81Important
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
251
¥ million (year-on-year increase in revenue)
Wording
Conditional
How definitive the wording is.

Contents of this document

Earnings PresentationSecond quarter of FY2027/310 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Net Sales¥5,124 million+5.1%
Operating profit¥483 million-4.1%
Ordinary income¥448 million-10.0%
Net income¥340 million-7.4%
Gross Profit Margin42.6%
Operating profit margin9.4%
Results for the three months of the current quarter
Biomaterials Business
Net Sales
¥1,895 million
Operating profit
¥322 million
Resource-Circulation Business
Net Sales
¥456 million
Operating profit
¥22 million
Full-year earnings forecast
Net Sales
¥10,823 million
Gross profit
¥4,741 million
Operating profit
¥1,287 million
Ordinary income
¥1,255 million
Profit attributable to owners of the parent
¥891 million
Progress against full-year forecast　通期の予想に対して、いまどこまで進んだかの割合です。
Net Sales47.3%
Gross profit46.1%
Operating profit37.6%
Ordinary income35.7%
Profit attributable to owners of the parent38.3%
What the company explained in this material
Breakdown of Factors Affecting the ChangeReasons cited by the Company for the change in the figures.
  • Biomaterials Business+¥215 million
  • Resource-Circulation Business+¥14 million
  • Other+¥20 million
  • Personnel investment, cost of sales, etc.-¥81 million
  • Depreciation and amortization, etc.-¥43 million
  • Higher purchases, etc.-¥60 million
  • Other-¥31 million
  • Other-¥93 million
New initiatives
  • Operation of Nagoya Narumi CE Park
  • Advancement of plans for 7 newly established or expanded locations
  • Establishment of a new shipping method using coastal vessels
  • Progressive dividend policy with an interim dividend of ¥16 and an annual dividend of ¥32
Key KPIsA metric the company considers important as a management benchmark.
  • EBITDA¥866 million
    Year on year against the same period last year+2.7%
  • EBITDA margin16.9 %
  • Biomaterials business recycling rate100 %
  • Resource-circulation business recycling rate81.9 %
Segment results
Biomaterials Business
Net Sales
¥3,779 million
Year-on-year change in net sales6.2
Profit
¥454 million
Year-on-Year Change in Profit0.8
Resource-Circulation Business
Net Sales
¥831 million
Year-on-year change in net sales1.8
Profit
¥22 million
Year-on-Year Change in Profit-37.8
Other businesses
Net Sales
¥693 million
Year-on-year change in net sales1
Profit
¥13 million
Year-on-Year Change in Profit-42.8
Medium-term management plan targets
Target fiscal yearFiscal year ending March 2030
Net Sales
140 Hundred million yen
Operating profit
25 Hundred million yen
Operating profit margin
17 %
ROEOver 15%
Financial targets
ROE
TargetOver 15%
Actual results15.1% for the fiscal year ended March 2026
Number of stores and locations
Number of locations at period end23 Locations
Locations opened and closed during the periodNagoya Narumi CE Park began operations in October 2026
Number of employees
Number of Employees510 People
Annual Dividend
Annual dividend per share
¥32
Interim Dividend
¥16
Payout ratio
Guideline of 35% or higher (forecast of 41.7% for the fiscal year ending March 2027)
Contents of this document
ItemDetails
Document typeEarnings Presentation
Fiscal Period CoveredSecond quarter of FY2027/3
Net Sales¥5,124 million (YoY +5.1%)
Operating profit¥483 million (YoY -4.1%)
Ordinary income¥448 million (YoY -10.0%)
Net income¥340 million (YoY -7.4%)
Gross Profit Margin42.6%
Operating profit margin9.4%
Results for the three months of the current quarterBiomaterials Business Net Sales ¥1,895 million / Operating profit ¥322 million / Resource-Circulation Business Net Sales ¥456 million / Operating profit ¥22 million
Full-year earnings forecastNet Sales ¥10,823 million / Gross profit ¥4,741 million / Operating profit ¥1,287 million / Ordinary income ¥1,255 million / Profit attributable to owners of the parent ¥891 million
Progress against full-year forecastNet Sales 47.3% / Gross profit 46.1% / Operating profit 37.6% / Ordinary income 35.7% / Profit attributable to owners of the parent 38.3%
Segment resultsBiomaterials Business Net Sales ¥3,779 million / Year-on-year change in net sales 6.2 / Profit ¥454 million / Year-on-Year Change in Profit 0.8 / Resource-Circulation Business Net Sales ¥831 million / Year-on-year change in net sales 1.8 / Profit ¥22 million / Year-on-Year Change in Profit -37.8 / Other businesses Net Sales ¥693 million / Year-on-year change in net sales 1 / Profit ¥13 million / Year-on-Year Change in Profit -42.8
Breakdown of Factors Affecting the ChangeFactors Biomaterials Business / Amount +¥215 million, Factors Resource-Circulation Business / Amount +¥14 million, Factors Other / Amount +¥20 million, Factors Personnel investment, cost of sales, etc. / Amount -¥81 million, Factors Depreciation and amortization, etc. / Amount -¥43 million, Factors Higher purchases, etc. / Amount -¥60 million, Factors Other / Amount -¥31 million, Factors Other / Amount -¥93 million
Key KPIsIndicator name EBITDA / Value ¥866 million / Year on year against the same period last year ¥2.7 million, Indicator name EBITDA margin / Value 16.9 % / Year on year against the same period last year Not disclosed, Indicator name Biomaterials business recycling rate / Value 100 % / Year on year against the same period last year Not disclosed, Indicator name Resource-circulation business recycling rate / Value 81.9 % / Year on year against the same period last year Not disclosed
Number of stores and locationsNumber of locations at period end 23 Locations / Locations opened and closed during the period Nagoya Narumi CE Park began operations in October 2026
Number of employeesNumber of Employees 510 People / Changes and hiring plans during the period Not disclosed
Medium-term management plan targetsTarget fiscal year Fiscal year ending March 2030 / Net Sales 140 Hundred million yen / Operating profit 25 Hundred million yen / Operating profit margin 17 % / ROE Over 15%
Financial targetsROE Target Over 15% / Actual results 15.1% for the fiscal year ended March 2026
Annual DividendAnnual dividend per share ¥32 / Interim Dividend ¥16 / Year-end dividend Not disclosed
Payout ratioGuideline of 35% or higher (forecast of 41.7% for the fiscal year ending March 2027)
New initiativesOperation of Nagoya Narumi CE Park, Advancement of plans for 7 newly established or expanded locations, Establishment of a new shipping method using coastal vessels, Progressive dividend policy with an interim dividend of ¥16 and an annual dividend of ¥32
Items this document does not state (10)
Selling, general and administrative expensesSelf-assessment against the planUnit price and quantity metricsAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / ShareKey points of the Q&A

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Revenue increased due to the quantitative expansion of the biomaterials business, the expansion of the service area through the Nagoya CE Center, and the acquisition of new customers. Operating profit declined due to personnel investment, including base-pay increases, depreciation expenses associated with the operation of the Nagoya CE Center, and costs related to the shareholder benefit program.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Supplementary Financial Results Presentation for the Second Quarter of the Fiscal Year Ending March 2027 | FULUHASHI EPO CORPORATION (9221) timely disclosure | Komori